相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Epidemiology of Pediatric Inflammatory Bowel Disease: A Systematic Review of International Trends
Eric I. Benchimol et al.
INFLAMMATORY BOWEL DISEASES (2011)
Improvement in Growth of Children With Crohn Disease Following Anti-TNF-alpha Therapy Can Be Independent of Pubertal Progress and Glucocorticoid Reduction
S. Malik et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Systematic review: steroid withdrawal in anti-TNF-treated patients with inflammatory bowel disease
E. Bultman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy
S. Lichtiger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
R. Panaccione et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Tumor Necrosis Factor α Blockers and Malignancy in Children Forty-Eight Cases Reported to the Food and Drug Administration
Peter Diak et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review
Abderrahim Oussalah et al.
CURRENT DRUG TARGETS (2010)
Adalimumab Treatment in Children with Refractory Crohn's Disease
Yoram Rosenbach et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
Harry Sokol et al.
GUT (2010)
Oropharyngeal and Proximal Esophageal Involvement During Adalimumab Treatment of Crohn Disease
Kim-Doan Katrina Nguyen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Guidelines for the Management of Inflammatory Bowel Disease in Children in the United Kingdom
Bhupinder K. Sandhu et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Systematic Review of the Evidence Base for the Medical Treatment of Paediatric Inflammatory Bowel Disease
D. C. Wilson et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008)
G. T. Ho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn's Disease
Joel R. Rosh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's Disease
Franca Viola et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Konstantinos Karmiris et al.
GASTROENTEROLOGY (2009)
Fatal invasive pulmonary aspergillosis associated with adalimumab therapy
M. Manz et al.
GUT (2009)
Adalimumab Safety in Global Clinical Trials of Patients with Crohn's Disease
Jean-Frederic Colombel et al.
INFLAMMATORY BOWEL DISEASES (2009)
Adalimumab treatment in infliximab resistant pediatric patient with Crohn’s disease
Gábor Veres et al.
ORVOSI HETILAP (2009)
Crohn's disease: current treatment options
A. K. Akobeng
ARCHIVES OF DISEASE IN CHILDHOOD (2008)
Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease
Johan Van Limbergent et al.
GASTROENTEROLOGY (2008)
Hepatosplenic T cell lymphoma in inflammatory bowel disease
Matthew Shale et al.
GUT (2008)
Short-term Response to Adalimumab in Childhood Inflammatory Bowel Disease
Joshua D. Noe et al.
INFLAMMATORY BOWEL DISEASES (2008)
Adalimumab induces and maintains remission in severe, resistant paediatric Crohn disease
Faruk Hadziselimovic
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease
Hilary Mossop et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Safety and efficacy of adalimumab in pediatric patients with Crohn disease
Matthew J. Wyneski et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Resolution of non-small-cell lung cancer after withdrawal of anti-TNF therapy
Charles W. Lees et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The use of adalimumab in the management of refractory Crohn's disease
G. -T. Ho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease
Dan Turner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease
Thomas D. Walters et al.
INFLAMMATORY BOWEL DISEASES (2007)
Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study
L. Peyrin-Biroulet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children
Jeffrey Hyams et al.
GASTROENTEROLOGY (2007)
Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial
J. Hinojosa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
Ann Corken Mackey et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Adalimumab, a novel anti-tumor necrosis factor-α antibody in a child with refractory Crohn's disease
S Mian et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Prospective survey of childhood inflammatory bowel disease in the British Isles
A Sawczenko et al.
LANCET (2001)
分享论文
